essentials

Venture capital firms take only identifiable risks. The FDA “approval” is usually the greatest risk. Investing in a medical device where the FDA plan fails to achieve an FDA “approval” before the break-even point is NOT an investment any advisor could endorse. That is almost like presenting a plan to potential inventors showing a plan where only by a miracle - could the goal be reached. Investors would fee from such a plan. Showing them a plan without an irrefutable plan is virtually asking for a miracle.

Any medical device plan must show a clear method to either:

·        submit the application to the FDA, or

·        achieve FDA approval.

When C² conducts an FDA project on your invention, that is a significant step in the commercialization of the invention.